Clinical trial
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney…
NCT00081471 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00081471 |
|---|---|
| Title | A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis |
| Official title | A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | darbepoetin alfa, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 324 |
| Start date | Jun 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Apr 16, 2004 |
| Last update posted | Nov 2, 2016 |
| Countries | Australia, Belgium, Canada, France, Germany, Greece, Italy, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom and 1 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: